Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1996 3
2002 2
2004 6
2006 5
2007 3
2008 9
2009 11
2011 7
2012 4
2013 3
2014 5
2015 2
2016 7
2017 2
2018 3
2019 4
2020 5
2021 14
2022 10
2023 9
2024 7
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer.
Galan-Cobo A, Vokes NI, Qian Y, Molkentine D, Ramkumar K, Paula AG, Pisegna M, McGrail DJ, Poteete A, Cho S, Do MT, Karimi A, Kong Y, Solanki A, Karmokar A, Floc'h N, Hughes A, Sargeant R, Young L, Shen L, Kar G, Keshvani C, Arrechedera C, Hernandez S, Schlacher K, Wang J, Iyer S, Conway J, Keddar MR, Milo M, de Toma I, Critchlow SE, Barrett JC, Cosaert J, Lau A, Valge-Archer V, Byers LA, Barry ST, Heymach JV. Galan-Cobo A, et al. Among authors: de toma i. Cancer Cell. 2025 Aug 11;43(8):1530-1548.e9. doi: 10.1016/j.ccell.2025.06.011. Epub 2025 Jul 10. Cancer Cell. 2025. PMID: 40645185 Free article.
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.
Rimini M, Masi G, Lonardi S, Nichetti F, Pressiani T, Lavacchi D, Jessica L, Giordano G, Scartozzi M, Tamburini E, Pastorino A, Rapposelli IG, Daniele B, Martinelli E, Garajova I, Aprile G, Schirripa M, Formica V, Salani F, Winchler C, Bergamo F, Balsano R, Gusmaroli E, Lorenzo A, Landriscina M, Pretta A, Toma I, Pirrone C, Diana A, Leone F, Brunetti O, Brandi G, Garattini SK, Satolli MA, Rossari F, Fornaro L, Niger M, Zanuso V, De Rosa A, Ratti F, Aldrighetti L, De Braud F, Foti S, Rizzato MD, Vivaldi C, Stefano C, Rimassa L, Antonuzzo L, Casadei-Gardini A. Rimini M, et al. Among authors: toma i. Target Oncol. 2024 May;19(3):359-370. doi: 10.1007/s11523-024-01060-1. Epub 2024 May 1. Target Oncol. 2024. PMID: 38691295
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAFV600E wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial.
Ciardiello D, Boscolo Bielo L, Napolitano S, Martinelli E, Troiani T, Nicastro A, Latiano TP, Parente P, Maiello E, Avallone A, Normanno N, Pisconti S, Nisi C, Bordonaro R, Russo AE, Tamburini E, Toma I, Lotesoriere C, Vallarelli S, Zampino MG, Fazio N, Curigliano G, De Vita F, Ciardiello F, Martini G; CAPRI-2 GOIM study group. Ciardiello D, et al. Among authors: toma i. Ann Oncol. 2024 Dec;35(12):1105-1115. doi: 10.1016/j.annonc.2024.08.2334. Epub 2024 Aug 29. Ann Oncol. 2024. PMID: 39214459
Transposable elements in brain health and disease.
Ahmadi A, De Toma I, Vilor-Tejedor N, Eftekhariyan Ghamsari MR, Sadeghi I. Ahmadi A, et al. Among authors: de toma i. Ageing Res Rev. 2020 Dec;64:101153. doi: 10.1016/j.arr.2020.101153. Epub 2020 Sep 22. Ageing Res Rev. 2020. PMID: 32977057 Review.
Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders.
Xicota L, De Toma I, Maffioletti E, Pisanu C, Squassina A, Baune BT, Potier MC, Stacey D, Dierssen M; European College of Neuropsychopharmacology (ECNP) Pharmacogenomics & Transcriptomics Thematic Workgroup. Xicota L, et al. Among authors: de toma i. Eur Neuropsychopharmacol. 2022 Jan;54:41-53. doi: 10.1016/j.euroneuro.2021.10.005. Epub 2021 Nov 4. Eur Neuropsychopharmacol. 2022. PMID: 34743061 Review.
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial.
Ciardiello D, Boscolo Bielo L, Napolitano S, Latiano TP, De Stefano A, Tamburini E, Toma I, Bordonaro R, Russo AE, Pisconti S, Nisi C, Lotesoriere C, Vallarelli S, Lonardi S, Iacono D, Cremolini C, Tortora G, Tagliaferri P, Pietrantonio F, Rosati G, Lucenti A, Scartozzi M, Brunetti O, Cinieri S, Zampino MG, Zaniboni A, Berardi R, Paoletti G, Febbraro A, Martinelli E, Troiani T, Cioli E, Normanno N, Di Maio M, Parente P, Fazio N, Curigliano G, De Vita F, Avallone A, Maiello E, Ciardiello F, Martini G. Ciardiello D, et al. Among authors: toma i. ESMO Open. 2025 Apr;10(4):104511. doi: 10.1016/j.esmoop.2025.104511. Epub 2025 Mar 18. ESMO Open. 2025. PMID: 40107157 Free PMC article. Clinical Trial.
Multiphoton imaging of renal regulatory mechanisms.
Peti-Peterdi J, Toma I, Sipos A, Vargas SL. Peti-Peterdi J, et al. Among authors: toma i. Physiology (Bethesda). 2009 Apr;24:88-96. doi: 10.1152/physiol.00001.2009. Physiology (Bethesda). 2009. PMID: 19364911 Free PMC article. Review.
114 results